Osaic Holdings’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12
Closed -$972 7539
2024
Q1
$972 Hold
12
﹤0.01% 6687
2023
Q4
$5.64K Hold
12
﹤0.01% 6118
2023
Q3
$5.88K Buy
12
+7
+140% +$781 ﹤0.01% 6197
2023
Q2
$3.95K Sell
5
-1
-17% -$133 ﹤0.01% 6416
2023
Q1
$3.25K Buy
+6
New +$990 ﹤0.01% 6527
2022
Q3
Sell
-16
Closed -$1K 7417
2022
Q2
$1K Hold
16
﹤0.01% 7113
2022
Q1
$1K Buy
16
+14
+700% +$2.36K ﹤0.01% 7080
2021
Q4
$6K Buy
+2
New +$585 ﹤0.01% 6548
2021
Q2
Sell
-3
Closed -$2K 7075
2021
Q1
$2K Buy
+3
New +$435 ﹤0.01% 6498
2020
Q4
Sell
-2
Closed -$1K 6511
2020
Q3
$1K Buy
+2
New +$139 ﹤0.01% 6038

Other funds holding MRNA

Osaic Holdings's MRNA Position: Q1 2026 in Review

Osaic Holdings reduced its Moderna (MRNA) stake by 8.3% in Q1 2026, selling an estimated $169K and leaving 40,197 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Osaic Holdings first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $65.1M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Osaic Holdings held 40,197 shares of Moderna worth $2.04M as of Q1 2026.
  • Osaic Holdings sold 3,627 Moderna shares in Q1 2026, an estimated $169K.
  • Moderna made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2060 holding.
  • Osaic Holdings first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Moderna position peaked at $65.1M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.